CRP and inflammatory bowel disease: To assess the robustness of the IMLCI under alternative outcome specifications, a sensitivity analysis was performed using the original laboratory-inclusive definition of severe IBD, which incorporated CRP, WBC, ALT/AST, and albumin thresholds.